CODX_OUT_1 [2025-04-02 19:58:58 -0400] 1997 Bytes | 607 tokens | Cum: 607 tkns (7.59% of 8k)
==========================================================================

Booyah, my friends! It's already 7:58:58 PM on Wed Apr 02, 2025 -0400, and I've got my eyes locked on (CODX), pushing up to 0.388 from 0.3278. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: CODX (CODX)
IPO: IPO date unknown
Shares Outstanding: 33,570,000
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange: XNAS

Here's the first list of news for :

C1 - Today 12:00PM - All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy
C2 - Mar-28-25 08:45AM - Q4 2024 Co-Diagnostics Inc Earnings Call
C3 - Mar-28-25 08:45AM 03:03AM - Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...
C4 - Mar-27-25 07:05PM - Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates
C5 - Mar-27-25 07:05PM 06:44PM - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript
C6 - Mar-27-25 07:05PM 04:01PM - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
C7 - Mar-19-25 05:20PM - Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates
C8 - Mar-13-25 09:30AM - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on (CODX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

CODX_OUT_3 [2025-04-02 19:59:00 -0400] 436 Bytes | 141 tokens | Cum: 750 tkns (9.38% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy**
Date: Today 12:00PM
Source: (Zacks)
URL: /news/15147/all-you-need-to-know-about-codiagnostics-codx-rating-upgrade-to-buy

**No additional content available.**

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CODX_OUT_5 [2025-04-02 19:59:01 -0400] 953 Bytes | 301 tokens | Cum: 1078 tkns (13.48% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-01T21:05:46Z - 12 Health Care Stocks Moving In Tuesday's After-Market Session - bioAffinity Technologies (NASDAQ:BI...
A2 - 2025-03-28T00:06:00Z - Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates...
A3 - 2025-03-27T22:44:59Z - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript...
A4 - 2025-03-27T20:03:05Z - Co-Diagnostics GAAP EPS of -$1.24 misses by $0.02, revenue of $3.91M misses by $0.23M...
A5 - 2025-03-27T08:32:15Z - Earnings Scheduled For March 27, 2025 - Ascentage Pharma Group (NASDAQ:AAPG), Abacus Global Manageme...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CODX_OUT_7 [2025-04-02 19:59:05 -0400] 1098 Bytes | 337 tokens | Cum: 1417 tkns (17.71% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Health Care Stocks Moving In Tuesday's After-Market Session - bioAffinity Technologies (NASDAQ:BIAF), Biodesix (NASDAQ:BDSX)**Date: 2025-04-01Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44596319/12-health-care-stocks-moving-in-tuesdays-after-market-sessionGainers Reshape Lifesciences RSLS stock rose 26.7% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $6.7 million. bioAffinity Technologies BIAF stock rose 11.92% to $1.22. The market value of their outstanding shares is at $19.0 million. As per the news, the Q4 earnings report came out yesterday. Biodesix BDSX stock moved upwards by 10.24% to $0.67. The company's market cap stands at $97.0 million. DIH Holding US DHAI shares moved upwards by 8.88% to $0.24. The company's market cap stands at $11.5 mi

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CODX_OUT_9 [2025-04-02 19:59:06 -0400] 823 Bytes | 278 tokens | Cum: 1843 tkns (23.04% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-10-24T12:15:00Z - Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology
B2 - 2024-04-18T11:10:02Z - Elevance Health (ELV) Beats Q1 Earnings Estimates
B3 - 2024-02-21T23:30:03Z - Icon PLC (ICLR) Q4 Earnings Surpass Estimates
B4 - 2023-08-10T21:15:09Z - Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates
B5 - 2023-08-09T12:50:35Z - Sharecare, Inc. (SHCR) Reports Q2 Loss, Tops Revenue Estimates
B6 - 2023-05-12T08:08:31Z - Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CODX_OUT_11 [2025-04-02 19:59:09 -0400] 772 Bytes | 213 tokens | Cum: 2058 tkns (25.72% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/pressreleases/24/10/g41515246/infectious-disease-diagnostics-market-to-reach-usd-43-09-billion-by-2031-skyquest-technologyThe global infectious disease diagnostics market is projected to reach $43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period. The market is driven by advancements in diagnostic technologies, rising cases of infectious diseases, and increased R&D funding.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CODX_OUT_13 [2025-04-02 19:59:09 -0400] 1048 Bytes | 291 tokens | Cum: 2414 tkns (30.18% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-27 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULT OF OPER

The following managements discussion and analysis of financial condition and results of operations describes the principal factors affecting the results of our operations, financial con...

S2 - 2025-03-27 8-K Item 2.02. Results of Oper and Fin Cond.

On March 27, 2025, Co-Diagnostics, Inc. (the Company) issued a press release announcing financial results for its year ended December 31, 2024. The full text of the press release, which includes information regarding the...

S3 - 2024-11-07 10-Q PART I. FIN INFO

Item 1. Fin Stmnts

CO DIAGNOSTICS, INC. & SUBSIDIARIES

COND CONS BAL SHEETS

(Unaudited)

September 30, 2024 December 31, 2023 Assets Curr assets Cash and cash equiv $ 10,797,630 $ 14,916,878 Marketable...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CODX_OUT_15 [2025-04-02 19:59:13 -0400] 1098 Bytes | 277 tokens | Cum: 2693 tkns (33.66% of 8k)
==========================================================================

Showing S2 (chunk 1 of 2): S2:
Item 2.02. Results of Operations and Financial Condition.

On March 27, 2025, Co-Diagnostics, Inc. (the Company) issued a press release announcing financial results for its year ended December 31, 2024. The full text of the press release, which includes information regarding the Companys use of a non-GAAP financial measure, is furnished as Exhibit 99.1 to this Form 8-K.

The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. Furthermore, the information contained in this Item 2.02 or Exhibit 99.1 shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, except as shall be expressly se

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CODX_OUT_17 [2025-04-02 19:59:22 -0400] 4269 Bytes | 1224 tokens | Cum: 4027 tkns (50.34% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+-------------------------+-------------------------+
| Volume: 129,096 | Perf Month: -26.55% | Option/Short: Yes / Yes | Sales Y/Y TTM: -88.70% |
+---------------------+-----------------------+-------------------------+-------------------------+
| Avg Volume: 236.01K | Perf Quarter: -48.85% | Short Float: 0.65% | ROE: -53.65% |
+---------------------+-----------------------+-------------------------+-------------------------+
| Rel Volume: 0.55 | Index: - | Short Ratio: 0.86 | ROI: -67.76% |
+---------------------+-----------------------+-------------------------+-------------------------+
| RSI (14): 32.44 | Market Cap: 12.02M | Short Interest: 0.20M | Sales Surprise: -60.19% |
+---------------------+-----------------------+-------------------------+-------------------------+
| ATR (14): 0.06 | Shs Outstand: 33.05M | Beta: 0.87 | EPS Surprise: -5.88% |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA20: -19.89% | Shs Float: 30.98M | Sales Q/Q: -95.80% | P/E: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA50: -38.96% | Inst Own: 17.05% | Sales past 5Y: 6885.34% | Earnings: Mar 27 AMC |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA200: -64.59% | Insider Own: 7.73% | Employees: 132 | |
+---------------------+-----------------------+-------------------------+-------------------------+
| Perf Week: -14.07% | Insider Trans: 0.00% | Debt/Eq: 0.04 | |
+---------------------+-----------------------+-------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 3915160.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -37639008.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.358
Average Volume: 249145.87
30-Day High: 0.56
30-Day Low: 0.3096

[Detailed Financials: TTM 2024]
- Total Assets: $63,999,919.0
- Total Liabilities: $9,688,001.0
- Total Equity: $54,311,918.0
- Current Assets: $32,291,698.0
- Current Liabilities: $7,315,718.0

[Income Statement: TTM 2024]
- Revenue: $3,915,160.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.24

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-11,980,334.0

[Detailed Financials: FY 2024]
- Total Assets: $63,999,919.0
- Total Liabilities: $9,688,001.0
- Total Equity: $54,311,918.0
- Current Assets: $32,291,698.0
- Current Liabilities: $7,315,718.0

[Income Statement: FY 2024]
- Revenue: $3,915,160.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.24

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-11,980,334.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

CODX_OUT_19 [2025-04-02 19:59:24 -0400] 676 Bytes | 167 tokens | Cum: 4400 tkns (55.00% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CODX_IN_21 [2025-04-02 19:59:25 -0400] 126 Bytes | 29 tokens | Cum: 4497 tkns (56.21% of 8k)
==========================================================================

====================================
[2025-04-02 19:59:25] # Analysis Completed
Elapsed Time: 27.22 seconds